(Q24612550)

English

Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

author name string

Dong Xi

1

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

Yan-Chun Li

2

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

Melissa A Snyder

3

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

Ruby Y Gao

4

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

Alicia E Adelman

5

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

Wentong Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

Jed S Shumsky

7

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

Wen-Jun Gao

8

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

language of work or name

0 references

publication date

16 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

1260-1274

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Identification of a serotonin/glutamate receptor complex implicated in psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Genetic enhancement of learning and memory in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

LTP inhibits LTD in the hippocampus via regulation of GSK3beta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Regulation of neurotransmitter release by metabotropic glutamate receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Modulation of D2R-NR2B interactions in response to cocaine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia

1 reference

https://api.crossref.org/works/10.1038/NPP.2011.12

22 April 2017

NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

7 April 2017

Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

A new class of molecular targeted radioprotectors: GSK-3beta inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Dizocilpine (MK-801) induces distinct changes of N-methyl-D-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

A specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: application of laser microdissection technique

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

A signaling pathway AKTing up in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Schizophrenia: moving beyond monoamine antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

The role of GSK-3 in synaptic plasticity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

The role of glycogen synthase kinase-3beta in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Regulation of NMDA receptors by phosphorylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Metabotropic glutamate receptors as drug targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

The Akt-GSK-3 signaling cascade in the actions of dopamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

The trick of the tail: protein-protein interactions of metabotropic glutamate receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

NMDA receptors and schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Role of distinct NMDA receptor subtypes at central synapses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Glutamate as a therapeutic target in psychiatric disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

The NMDA receptor hypofunction model of psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Bringing order to the glutamate chaos in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Diverse psychotomimetics act through a common signaling pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Akt as a mediator of cell death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Direct and indirect modulation of the N-methyl D-aspartate receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

GSK-3 and the neurodevelopmental hypothesis of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Immunohistochemical distribution of metabotropic glutamate receptor subtypes mGluR1b, mGluR2/3, mGluR4a and mGluR5 in human hippocampus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Glutamate receptor dysfunction and schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

27 September 2017

Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

30 May 2018

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

30 May 2018

Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

30 May 2018

Changes in subcellular localization of metabotropic glutamate receptor subtypes during postnatal development of mouse thalamus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

30 May 2018

Ionotropic and metabotropic glutamate receptors show unique postsynaptic, presynaptic, and glial localizations in the dorsal cochlear nucleus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

30 May 2018

Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

30 May 2018

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

30 May 2018

Drug-reinforced responding: rapid determination of dose-response functions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

30 May 2018

Increased phosphorylation of Ser473-Akt, Ser9-GSK-3beta and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Tyrosine phosphorylation of the 2B subunit of the NMDA receptor is necessary for taste memory formation.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Glycogen synthase kinase 3 regulates N-methyl-D-aspartate receptor channel trafficking and function in cortical neurons.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Atypical antipsychotics and a Src kinase inhibitor (PP1) prevent cortical injury produced by the psychomimetic, noncompetitive NMDA receptor antagonist MK-801.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Metabotropic glutamate receptor agonists for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

The role of Akt-GSK-3beta signaling and synaptic strength in phencyclidine-induced neurodegeneration.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Glutamate receptor subunits are altered in forebrain and cerebellum in rats chronically exposed to the NMDA receptor antagonist phencyclidine

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

NMDA receptor activation limits the number of synaptic connections during hippocampal development.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Glycogen synthase kinase (GSK)-3beta levels and activity in a neurodevelopmental rat model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Effects of phencyclidine on immediate early gene expression in the brain

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Blockade of glutamate transporters leads to potentiation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex via group II metabotropic glutamate receptor activation

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

The effects of repeated administrations of MK-801 on ERK and GSK-3beta signalling pathways in the rat frontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Group II metabotropic glutamate receptors enhance NMDA receptor currents via a protein kinase C-dependent mechanism in pyramidal neurones of rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Clozapine potentiation of N-methyl-D-aspartate receptor currents in the nucleus accumbens: role of NR2B and protein kinase A/Src kinases

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2011.12

21 January 2018

Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

28 November 2018

The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

28 November 2018

Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079418

28 November 2018

Schizophrenia drug says goodbye to dopamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21326193

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic phencyclidine administration reduces the expression and editing of specific glutamate receptors in rat prefrontal cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/21326193

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glutamate receptor expression in schizophrenic brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/21326193

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic blockade of N-methyl-D-aspartate receptors alters gamma-aminobutyric acid type A receptor peptide expression and function in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/21326193

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21326193

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MK801 induces late regional increases in NMDA and kainate receptor binding in rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/21326193

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/21326193

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NPP.2011.12

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24612550&oldid=2175208795"